Search Results - "FRIEDERICH, P. W"

Role of colonoscopic biopsy in distinguishing between Crohn’s disease and intestinal tuberculosis by Kirsch, R, Pentecost, M, de M Hall, P, Epstein, D P, Watermeyer, G, Friederich, P W

“…Background: The histological differential diagnosis of Crohn’s disease and intestinal tuberculosis can be very challenging, as both are chronic granulomatous…”
Get full text

Incidence of venous thromboembolism in families with inherited thrombophilia by Simioni, P, Sanson, B J, Prandoni, P, Tormene, D, Friederich, P W, Girolami, B, Gavasso, S, Huisman, M V, Büller, H R, Wouter ten Cate, J, Girolami, A, Prins, M H

“…The risk of spontaneous or risk-period related venous thromboembolism in family members of symptomatic carriers of antithrombin (AT), protein C (PC) or protein…”
Get more information

The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study by Sanson, Bernd-Jan, Simioni, Paolo, Tormene, Daniela, Moia, Marco, Friederich, Philip W., Huisman, Menno V., Prandoni, Paolo, Bura, Alessandra, Rejtő, László, Wells, Philip, Mannucci, Pier M., Girolami, Antonio, Büller, Harry R., Prins, Martin H.

“…Deficiencies of antithrombin, protein C, and protein S are associated with an increased risk of venous thromboembolism. The objective of this study was to…”
Get full text

Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women : Implications for prophylaxis by FRIEDERICH, P. W, SANSON, B.-J, SIMIONI, P, ZANARDI, S, HUISMAN, M. V, KINDT, I, PRANDONI, P, BÜLLER, H. R, GIROLAMI, A, PRINS, M. H

“…It has been reported that women with an inherited deficiency of antithrombin, protein C, or protein S have an increased risk for developing venous…”
Get full text

Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor by Minnema, M C, Friederich, P W, Levi, M, von dem Borne, P A, Mosnier, L O, Meijers, J C, Biemond, B J, Hack, C E, Bouma, B N, ten Cate, H

“…Recent in vitro studies have shown that fibrinolytic activity may be attenuated by a thrombin-activatable fibrinolysis inhibitor (TAFI), which is activated by…”
Get full text

The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women by Sanson, B J, Friederich, P W, Simioni, P, Zanardi, S, Hilsman, M V, Girolami, A, ten Cate, J W, Prins, M H

“…Hereditary deficiencies of the naturally occurring anticoagulants are well recognized conditions predisposing to recurrent venous thromboembolism. Since…”
Get more information

Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits by FRIEDERICH, P. W, LEVI, M, BIEMOND, B. J, CHARLTON, P, TEMPLETON, D, VAN ZONNEVELD, A. J, BEVAN, P, PANNEKOEK, H, CATE, J. W. T

“…Elevated levels of plasminogen activator inhibitor 1 (PAI-1) have been associated with the occurrence of thrombotic disease, and inhibition of PAI-1 activity…”
Get full text

The effect of the administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study by Friederich, P W, Geerdink, M G, Spataro, M, Messelink, E J, Henny, C P, Büller, H R, Levi, M

“…Transabdominal retropubic prostatectomy is associated with significant perioperative blood loss, often requiring blood transfusion. However, the administration…”
Get more information

Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo by BIEMOND, B. J, FRIEDERICH, P. W, KOSCHINSKY, M. L, LEVI, M, SANGRAR, W, XIA, J, BÜLLER, H. R, TEN CATE, J. W

“…In many case-control as well as epidemiological studies, increased lipoprotein(a) [Lp(a)] levels are considered to constitute an independent risk factor for…”
Get full text

Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis by BIEMOND, B. J, FRIEDERICH, P. W, LEVI, M, VLASUK, G. P, BÜLLER, H. R, TEN CATE, J. W

“…In the pathogenesis of (recurrent) thrombosis, clot-associated thrombin appears to play an important role. Antithrombin III-independent thrombin inhibitors…”
Get full text

Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor by Friederich, P W, Keller, T T, Biemond, B J, Peters, R J, Hornberger, W, Büller, H R, Levi, M

“…Current antithrombotic compounds have several limitations in clinical practice. The present study was designed to investigate a novel orally available direct…”
Get more information

Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects by de Jonge, Evert, Friederich, Philip W, Vlasuk, George P, Rote, William E, Vroom, Margaretha B, Levi, Marcel, van der Poll, Tom

“…The activation of coagulation has been shown to contribute to proinflammatory responses in animal and in vitro experiments. Here we report that the activation…”
Get full text

Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects by FRIEDERICH, Philip W, LEVI, Marcel, BAUER, Kenneth A, VLASUK, George P, ROTE, William E, BREEDERVELD, Daan, KELLER, Tijmen, SPATARO, Marco, BARZEGAR, Samad, BÜLLER, Harry R

“…In view of the central role of the tissue factor-factor VIIa pathway in the initiation of blood coagulation, novel therapeutic strategies aimed at inhibiting…”
Get full text

Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits by Levi, Marcel, Friederich, Philip W, Middleton, Sarah, Groot, Philip G. de, Wu, Ya Ping, Harris, Roy, Biemond, Bart J, Heijnen, Harry F.G, Levin, Jack, Cate, Jan Wouter ten

“…Severe thrombocytopenia frequently occurs in patients receiving chemotherapy and in patients with autoimmune disorders. Thrombocytopenia is associated with…”
Get full text

Successful treatment with recombinant factor VIIa of therapy‐resistant severe bleeding in a patient with acquired von Willebrand disease by Friederich, Philip W., Wever, Peter C., Briët, Ernest, Doorenbos, Cornelis J., Levi, Marcel

“…We describe an elderly man who presented with life‐threatening hematuria and gastrointestinal bleeding caused by acquired von Willebrand disease associated…”
Get full text

Retrieval of chronic hepatitis B patients in the Utrecht region in the Netherlands by Dimmendaal, M, Kracht, P A M, Dijkstra, S, Arends, J E, Woonink, F, Behalf Of The Reach Working Group, On

“…In the Netherlands, approximately 200 patients die annually from a chronic hepatitis B (CHB) infection, even though effective antiviral treatment is available…”
Get full text

Late Renaissance, Baroque or Counter-Reformation? by Friederich, W. P.

Get full text

Furman Studies by Friederich, W. P.

Get full text

Patient‐controlled analgesia versus continuous infusion of morphine during vaso‐occlusive crisis in sickle cell disease, a randomized controlled trial by van Beers, Eduard J., van Tuijn, Charlotte F.J., Nieuwkerk, Pythia T., Friederich, Philip W., Vranken, Jan H., Biemond, Bart J.

“…Intravenous morphine is the treatment of choice for severe pain during vaso‐ occlusive crisis in sickle cell disease (SCD). However, side effects of morphine…”
Get full text

A Department of American and Comparative Literature by Fkiederich, W. P., Gohdes, Clarence

Get full text